Add Company
Join Now

March Biosciences Revenue and Competitors

License our Company Data API

Houston, TX USA

Location

$33M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • March Biosciences's estimated annual revenue is currently $2.8M per year.(i)
  • March Biosciences's estimated revenue per employee is $155,000
  • March Biosciences's total funding is $33M.

Employee Data

  • March Biosciences has 18 Employees.(i)
  • March Biosciences grew their employee count by 100% last year.

March Biosciences's People

NameTitleEmail/Phone
1
Cofounder & CEOReveal Email/Phone
2
CSO, Co-FounderReveal Email/Phone
3
COOReveal Email/Phone
4
Acting Chief Medical OfficerReveal Email/Phone
5
Senior Director Research DevelopmentReveal Email/Phone
6
Director Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M1645%N/AN/A
#2
$13.8M89-7%N/AN/A
#3
$18.6M1203%$1.8MN/A
#4
$0.9M6-40%N/AN/A
#5
$4.2M270%N/AN/A
#6
$3.4M2247%N/AN/A
#7
$9.6M6229%N/AN/A
#8
$0.9M620%N/AN/A
#9
$1.7M1110%N/AN/A
#10
$15.2M98-8%N/AN/A
Add Company

What Is March Biosciences?

March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bio's lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The company's pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.

keywords:N/A

$33M

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

100%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M18N/AN/A
#2
$2.9M18N/AN/A
#3
$1.6M18N/AN/A
#4
$1.6M18N/AN/A
#5
$4.6M18-5%N/A